Development of a Novel Anti-Obesity Compound with Inhibiting Properties on the Lipid Accumulation in...
Development of a Novel Anti-Obesity Compound with Inhibiting Properties on the Lipid Accumulation in 3T3-L1 Adipocytes
About this item
Full title
Author / Creator
Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran , Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran , Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran , Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, Ardabil, Iran , Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran , Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran , Payab, Moloud , Hasani-Ranjbar, Shirin , Baeeri, Maryam , Rahimifard, Mahban , Arjmand, Babak , Haghi-Aminjan, Hamed , Abdollahi, Mohammad and Larijani, Bagher
Publisher
Iran: Pasteur Institute of Iran
Journal title
Language
English
Formats
Publication information
Publisher
Iran: Pasteur Institute of Iran
Subjects
More information
Scope and Contents
Contents
Obesity as a developing global challenge can be characterized by increase in adipocyte number and size arising from adipogenesis. Control of adipogenesis, as a potential strategy, can prevent and manage obesity. So far, the effectiveness of herbal medicine and active ingredients therapies for obesity and metabolic syndrome treatment has been invest...
Alternative Titles
Full title
Development of a Novel Anti-Obesity Compound with Inhibiting Properties on the Lipid Accumulation in 3T3-L1 Adipocytes
Authors, Artists and Contributors
Author / Creator
Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, Ardabil, Iran
Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran
Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Payab, Moloud
Hasani-Ranjbar, Shirin
Baeeri, Maryam
Rahimifard, Mahban
Arjmand, Babak
Haghi-Aminjan, Hamed
Abdollahi, Mohammad
Larijani, Bagher
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_74cae2fb619e43148b2c3170bedc66e2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_74cae2fb619e43148b2c3170bedc66e2
Other Identifiers
ISSN
1028-852X
E-ISSN
2008-823X
DOI
10.29252/ibj.24.3.155
